100 related articles for article (PubMed ID: 15794256)
1. [Smoking among thyroid patients].
Warmuz-Stangierska I; Czarnywojtek A; Florek E; Sowiński J
Przegl Lek; 2004; 61(10):1077-9. PubMed ID: 15794256
[TBL] [Abstract][Full Text] [Related]
2. [Tobacco smoking in patients with hyperthyroidism].
Warmuz-Stangierska I; Czarnywojtek A; Florek E; Rabska-Pietrzak B; Sawicka J; Sowiński J
Przegl Lek; 2005; 62(10):992-4. PubMed ID: 16521936
[TBL] [Abstract][Full Text] [Related]
3. Influence of smoking on Graves' disease with or without ophthalmopathy and nontoxic nodular goiter in Taiwan.
Chen YL; Chang TC; Chen CJ
J Formos Med Assoc; 1994 Jan; 93(1):40-4. PubMed ID: 7915579
[TBL] [Abstract][Full Text] [Related]
4. Incidental thyroid carcinoma in patients with Graves' disease.
Phitayakorn R; McHenry CR
Am J Surg; 2008 Mar; 195(3):292-7; discussion 297. PubMed ID: 18206132
[TBL] [Abstract][Full Text] [Related]
5. Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism.
Vestergaard P; Rejnmark L; Weeke J; Hoeck HC; Nielsen HK; Rungby J; Laurberg P; Mosekilde L
Thyroid; 2002 Jan; 12(1):69-75. PubMed ID: 11838733
[TBL] [Abstract][Full Text] [Related]
6. Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis.
Bossowski A; Czarnocka B; Bardadin K; Stasiak-Barmuta A; Urban M; Dadan J; Ratomski K; Bossowska A
Autoimmunity; 2008 Mar; 41(2):163-73. PubMed ID: 18324486
[TBL] [Abstract][Full Text] [Related]
7. Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases.
Bossowski A; Czarnocka B; Bardadin K; Urban M; Niedziela M; Dadan J
Horm Res; 2008; 70(3):155-64. PubMed ID: 18663316
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms associated with cigarette smoking and the risk of Graves' disease.
Bufalo NE; Santos RB; Cury AN; Andrade RA; Morari J; Morari EC; Leite JL; Monte O; Romaldini JH; Ward LS
Clin Endocrinol (Oxf); 2008 Jun; 68(6):982-7. PubMed ID: 17980001
[TBL] [Abstract][Full Text] [Related]
9. [Thyroid diseases in sub-Saharan Africa].
Sidibé el H
Sante; 2007; 17(1):33-9. PubMed ID: 17897900
[TBL] [Abstract][Full Text] [Related]
10. Application of mouse monoclonal antibodies for identification of antigen regions of human thyroid peroxidase in adolescents with Graves' disease and non-toxic multinodular goiter by flow cytometry.
Bossowski A; Stasiak-Barmuta A; Czarnocka B; Urban M; Dadan J
Autoimmunity; 2005 Dec; 38(8):605-11. PubMed ID: 16390813
[TBL] [Abstract][Full Text] [Related]
11. Interaction of lymphocytes and thyrocytes in Graves' disease and nonautoimmune thyroid diseases in immunohistochemical and ultrastructural investigations.
Ben-Skowronek I; Sierocinska-Sawa J; Szewczyk L; Korobowicz E
Horm Res; 2009; 71(6):350-8. PubMed ID: 19506393
[TBL] [Abstract][Full Text] [Related]
12. Graves' disease occurring after surgery of a multinodular goiter: a case report.
Heinzel A; Müller HW; Poeppel TD; Engers R; Hautzel H
Exp Clin Endocrinol Diabetes; 2009 Feb; 117(2):95-7. PubMed ID: 18563680
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
[TBL] [Abstract][Full Text] [Related]
14. [Cytofluorymetric evaluation of antigen regions of human thyroid peroxidase in patients with Graves' disease and non-toxic multinodular goiter using mouse monoclonal antibodies].
Bossowski A; Stasiak-Barmuta A; Czarnocka B; Urban M; Peter A; Dadan J
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(1):19-26. PubMed ID: 15850534
[TBL] [Abstract][Full Text] [Related]
15. Smoking and other lifestyle factors and the risk of Graves' hyperthyroidism.
Holm IA; Manson JE; Michels KB; Alexander EK; Willett WC; Utiger RD
Arch Intern Med; 2005 Jul; 165(14):1606-11. PubMed ID: 16043678
[TBL] [Abstract][Full Text] [Related]
16. The risk factors for malignancy in surgically treated patients for Graves' disease, toxic multinodular goiter, and toxic adenoma.
Senyurek Giles Y; Tunca F; Boztepe H; Kapran Y; Terzioglu T; Tezelman S
Surgery; 2008 Dec; 144(6):1028-36; discussion 1036-7. PubMed ID: 19041014
[TBL] [Abstract][Full Text] [Related]
17. Induction of stimulating thyrotropin receptor antibodies after radioiodine therapy for toxic multinodular goitre and Graves' disease measured with a novel bioassay.
Hovens GC; Heemstra KA; Buiting AM; Stokkel MP; Karperien M; Ballieux BE; Pereira AM; Romijn JA; Smit JW
Nucl Med Commun; 2007 Feb; 28(2):123-7. PubMed ID: 17198353
[TBL] [Abstract][Full Text] [Related]
18. Effect of stressful life events on the initiation of graves' disease.
Topcu CB; Celik O; Tasan E
Int J Psychiatry Clin Pract; 2012 Oct; 16(4):307-11. PubMed ID: 22136213
[TBL] [Abstract][Full Text] [Related]
19. Lack of mutations in the TSHr and Gsalpha genes in TSHr antibody negative Graves' disease.
Elgadi A; Frisk T; Larsson C; Wallin G; Höög A; Zedenius J; Norgren S
Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):516-21. PubMed ID: 16235153
[TBL] [Abstract][Full Text] [Related]
20. Incidence of radioiodine induced Graves' disease in patients with multinodular toxic goiter.
Meller J; Siefker U; Hamann A; Hüfner M
Exp Clin Endocrinol Diabetes; 2006 May; 114(5):235-9. PubMed ID: 16804797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
